# Thomas Kaiser

Source: https://onco.cc/people/thomas-kaiser/  
OnCo record `thomas-kaiser` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Physician who directs IQWiG, the German institute that produces the benefit assessments underpinning cancer drug pricing and coverage decisions.

## Summary

Dr. med. Thomas Kaiser is Director of the Institute for Quality and Efficiency in Health Care (IQWiG) in Cologne. He previously headed IQWiG's Drug Assessment department and has been a central figure in Germany's early benefit assessment (AMNOG) process for new medicines, including oncology drugs. He publishes on evidence standards, surrogate endpoints and health technology assessment methodology.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; health technology assessment; regulation
- Role: Director (Institutsleiter), IQWiG
- Specialisms: Health technology assessment; Evidence-based medicine; Drug benefit assessment

## Sources

- Institution profile: https://www.iqwig.de/ueber-uns/struktur-des-instituts/institutsleitung/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Kaiser+T%5BAuthor%5D+IQWiG

## Connected records

- institutions: [Gemeinsamer Bundesausschuss / IQWiG](https://onco.cc/institutions/g-ba-iqwig/)

---
JSON: https://onco.cc/api/v1/entities/thomas-kaiser.json